| Domestic Pharmaceutical Ingredients | Manufacturing and sale of pharmaceutical APIs and intermediates within India. | Strong regulatory compliance, experienced manufacturing team, and established domestic client relationships. | B2B, catering to domestic generic drug manufacturers and pharmaceutical firms. | Specialty APIs with proprietary manufacturing processes. | 19984 | 58 | Sales revenue from domestic pharmaceutical companies and distributors. | Direct sales with negotiated contracts tailored to customer requirements. | Rising Indian pharmaceutical demand, expansion of therapeutic segments, and enhanced manufacturing capabilities. | |
| Exports of Pharmaceuticals | Export of APIs and intermediates to global markets including USA, China, and Europe. | USFDA and Japan PMDA approvals, global customer trust, and continuous product innovation. | Primarily B2B, including generic and innovator drug manufacturers worldwide. | USFDA approved APIs for regulated markets. | 13763 | 40 | Export sales contracts with global pharmaceutical companies and partnerships. | Contract-based exports with volume discounts and long-term agreements. | Successful USFDA inspections, global API demand, and increasing product portfolio for regulated markets. | |
| Deemed Exports and Export Incentives | Domestic supplies qualifying for deemed export benefits and export incentive receipt from government schemes. | Policy compliance and effective utilization of export incentive schemes. | Indirectly linked to export-related manufacturing activities. | | 725 | 2 | Government incentives and benefits linked to export performance. | Incentives based on export volumes and policy provisions. | Government export promotion policies supporting export-oriented business. | |
